Professor Brundin is joined by fellow panelists Professor Tom Foltynie (UCL) who led the recent exenatide trial, Professor Nigel Greig and Dr. Dimitrios Kapogiannis from the National Institute of Ageing (NIA), and exenatide trial participant Penny Kustow, discussing the paper ‘What effects might exenatide have on non-motor symptoms in Parkinson’s disease: A post hoc analysis’ by Dr Dilan Athauda et al.’
